Publications - 2012
Serum microRNAs as biomarkers for recurrence in melanoma
Friedman, E. B., Shang, S., de Miera, E. V., Fog, J. U., Teilum, M. W., Ma, M. W., Berman, R. S., Shapiro, R. L., Pavlick, A. C., Hernando, E., Baker, A., Shao, Y., & Osman, I. (2012). Journal of translational medicine, 10, 155.
PMID: 22857597
Challenging the current paradigm of melanoma progression: brain metastasis as isolated first visceral site
Ma, M. W., Qian, M., Lackaye, D. J., Berman, R. S., Shapiro, R. L., Pavlick, A. C., Golfinos, J. G., Parker, E. C., Darvishian, F., Hernando, E., Shao, Y., & Osman, I. (2012). Neuro-oncology, 14(7), 849–858.
PMID: 22561799
MicroRNA-22 is induced by vitamin D and contributes to its antiproliferative, antimigratory and gene regulatory effects in colon cancer cells
Alvarez-Díaz, S., Valle, N., Ferrer-Mayorga, G., Lombardía, L., Herrera, M., Domínguez, O., Segura, M. F., Bonilla, F., Hernando, E., & Muñoz, A. (2012). Human molecular genetics, 21(10), 2157–2165.
PMID: 22328083
Histology-specific microRNA alterations in melanoma
Poliseno, L., Haimovic, A., Segura, M. F., Hanniford, D., Christos, P. J., Darvishian, F., Wang, J., Shapiro, R. L., Pavlick, A. C., Berman, R. S., Hernando, E., Zavadil, J., & Osman, I. (2012). The Journal of investigative dermatology, 132(7), 1860–1868.
PMID: 22551973
MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma.
Liu, Z., Liu, J., Segura, M. F., Shao, C., Lee, P., Gong, Y., Hernando, E., & Wei, J. J. (2012). The Journal of pathology, 228(2), 204–215.
PMID: 22322863